Infrared Bioeffect System for the Treatment of Cutaneous Warts
NCT ID: NCT03734003
Last Updated: 2021-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
88 participants
INTERVENTIONAL
2018-08-08
2020-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NCT06827938
A Cohort Study of Hyperthermia and Imiquimod for the Treatment of Flat Warts
NCT05146895
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
NCT06812065
Efficacy of Laser Versus Cryotherapy in the Treatment of Warts
NCT01808443
Carbon Dioxide Laser and Cryotherapy in Treatment of Warts
NCT03166137
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Controllable infrared bioeffect system for cutaneous warts
Controllable infrared bioeffect system at 44±2℃ for 30 mins on target lesion, at days of 1, 2, 3, 15, 16, 23, 30.
Common warts, plantar warts, and condyloma acuminata
controllable infrared bioeffect system
As an experimental arm, for patients with cutaneous warts
Liquid nitrogen cryotherapy for cutaneous warts
Liquid nitrogen crytotherapy at days 1, 15, 30.
liquid nitrogen
As an active comparator, for patients with cutaneous warts, liquid nitrogen crytherapy is applied
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
liquid nitrogen
As an active comparator, for patients with cutaneous warts, liquid nitrogen crytherapy is applied
controllable infrared bioeffect system
As an experimental arm, for patients with cutaneous warts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Hospital of China Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gao Xinghua
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xinghua Gao
Role: STUDY_DIRECTOR
No. 1 Hospital of China Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
No. 1 Hospital of China Medical University
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Qi RQ, Zhou J, Xiao B, Xu H, Qiao S, Zhu P, Xia L, Yang Y, Zhang L, Yan H, He C, Sun Y, Niu X, Zhang Y, Fu L, Wang X, Chen HD, Li S, Gao XH. Reprint of: Clearance of multiple cutaneous warts by targeting a single lesion: A randomized comparative evaluation of mild local hyperthermia versus cryotherapy. J Am Acad Dermatol. 2023 Mar;88(3):647-649. doi: 10.1016/j.jaad.2023.02.001. Epub 2023 Feb 18. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HH20180726
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.